Gulf Pharmaceutical Industries
- 1.520 AED
- -0.060
- -3.80%
Gulf Pharmaceutical Industries Stock Overview
View Company ProfileStock Summary
| Last Price (AED) | 1.520 |
| Prev. Close | 1.580 |
| Day Range | 1.500 - 1.590 |
| 52WK range | |
| Turnover (M AED) | 13.940 |
| Volume (M) | 9.050 |
| Number of Trades | 861 |
| Market Cap (M AED) | 1,755.946 |
| Change in Market Cap (M AED) | |
| VWAP (AED) | 1.540 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M AED) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Julphar sees lower net losses in H1-24; revenues up...
Abu Dhabi – Mubasher: The net losses of Gulf Pharmaceutical Industries (Julphar) retreated to AED 2.40 million in the first half (H1)...
Julphar turns profitable in Q1-24; accumulated losses...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners amounting to AED 1.90...
Julphar’s 2023 accumulated losses hit 30% of capital;...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) registered accumulated losses valued at AED 346.70 million as of 31...
Julphar turns to losses in 9M-23; accumulated losses...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) shifted to net losses attributable to the equityholders amounting to...
Julphar unveils H1-23 financials; accumulated losses...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to net losses attributable to the owners valued at AED 44.10 million in...
